Category Archives: Uncategorized

Healthy Vision Awareness!

According to the American Academy of Ophthalmology, approximately 37 million adults in America have age-related macular degeneration, cataract, diabetic retinopathy, or glaucoma, all of which can cause visual impairment or blindness. However, recent studies show that making healthy choices and getting regular eye exams can help reduce a person’s risk of vision loss. In support… Read More »



Dr. Pravin U. Dugel, MD – VIDEO: Brolucizumab treatment frequency predicted by first dosing interval

HONOLULU — The recent HAWK and HARRIER trials of Novartis’ brolucizumab for the treatment of neovascular age-related macular degeneration has helped researchers predict which patients will need an 8-week dosing regimen or a 12-week regimen with an almost 90% predictability rate, Pravin Dugel, MD, said at the Association for Research in Vision and Ophthalmology meeting… Read More »


Dr. Pravin U. Dugel: Ranibizumab Poses No Additional Risk of SAEs During Advanced Age

The use of the anti-VEGF agent ranibizumab for the treatment of neovascular age-related macular degeneration (nAMD) in patients aged 85 and over does not increase a patient’s risk of systemic serious adverse events (SAEs) like heart attack or stroke. Although the study, led by Pravin Dugel, MD, a clinical professor with the University of Southern… Read More »



Retinal Consultants of Arizona is Now Hiring Ophthalmic Technicians to Travel with our Amazing Physicians and Staff!

The ideal candidate will possess the following. Ophthalmology experience preferred, but willing to train the right candidate with Medical Assistant Experience. Medical Assistant must possess certification from an accredited program Must be able to work flexible hours and be able to travel via car or plane throughout the state. Photography (FA and OCT) experience helpful Must… Read More »


Dr. Pravin U. Dugel – Modern Retina from Ophthalmology Times

These novel strategies may change DME treatment paradigm By: Michelle Dalton, ELS; Reviewed by Pravin U. Dugel, MD There is no denying that the anti-vascular endothelial growth factor A (anti-VEGF-A) monotherapy has “absolutely revolutionized our treatment of diabetic macular edema (DME).” However, there is a subset of patients in whom the anti-VEGFs are not an… Read More »



Orbis International Welcomes New Members to its Board of Directors

Orbis welcomes Dr. Pravin Dugel, managing partner, Retinal Consultants of Arizona, and David Gitlin, President, UTC Aerospace Systems, to its Board of Directors. Pravin has been involved with Orbis since 2010 as a member of our Volunteer Faculty, specializing in retinal diseases including diabetic retinopathy. “I am extremely honored to join the Orbis Board of… Read More »


Dr. Pravin Dugel – Highlights from Day 1 of Retina Subspecialty Day 2017Findings from neovascular AMD studies a highlight from Day 1

Findings from neovascular AMD studies a highlight from Day 1 NEW ORLEANS – The 48-week results of the HAWK and HARRIER studies on brolucizumab (Novartis) for the treatment of neovascular age-related macular degeneration (AMD) were one of the highlights from Day 1 at Retina Subspecialty Day. Pravin Dugel, MD, (Phoenix, Ariz.) first described the antibody… Read More »